Search results
ASLAN Pharmaceuticals Limited's (NASDAQ:ASLN) recent 25% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Given the large stake in the stock by institutions, ASLAN Pharmaceuticals' stock price...
Mary J. Blige, Saweetie, And Tabitha Brown To Host ‘Recipe for Change: Amplifying Black Women’...
Vibe via Yahoo News· 2 years agoMary J. Blige’s 2022 continues to add more highlights to her legendary resume. The Queen of Hip-Hop...
Buckeye Valley Family YMCA holding STEM camps, learning opportunities
Newark Advocate via Yahoo News· 2 years agoBuckeye Valley Family YMCA is hosting summer camps this summer to expose area youth to STEM....
EXLUSIVE: SAB Biotherapeutics To Raise Up To $130M Via Preferred Equity To Advance Development Of...
Benzinga via Yahoo Finance· 7 months agoSAB Biotherapeutics (NASDAQ: SABS) has entered into a securities purchase agreement with certain...
Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Significant control over Repare Therapeutics by private equity firms implies that the...
10 Best Biotech Stocks Under $10
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we will take a look at the 10 best Biotech stocks under $10. You can skip our detailed analysis of the biotech industry’s outlook and go...
AN2 Therapeutics, Inc. (NASDAQ:ANTX) stock most popular amongst individual investors who own 29%,...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights The considerable ownership by individual investors in AN2 Therapeutics indicates that...
Individual investors account for 44% of GlycoMimetics, Inc.'s (NASDAQ:GLYC) ownership, while hedge...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls GlycoMimetics, Inc. (NASDAQ:GLYC), then you'll have to look...
With 66% ownership in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), institutional investors have a...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), then you'll...
